Iambic Therapeutics
IAM · NASDAQ
$15.83−$0.51 (−3.12%)TodayMarket open · · Delayed 15 min
Prev close $16.34
Who owns IAM
No institutional holdings are reported for Iambic Therapeutics.
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of IAM in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Manby Frederick R | Award | 793.20K | — |
| Manby Frederick R | Award | 132.20K | — |
| Olson Peter A | Award | 116.90K | — |
| Olson Peter A | Award | 19.50K | — |
| Vogelstein R Jacob | Award | 20.30K | — |
| Rachlin Evan Lockwood | Award | 20.30K | — |
| Miller Thomas F. | Award | 793.20K | — |
| Miller Thomas F. | Award | 132.20K | — |
| Josephson Neil | Award | 185.90K | — |
| Josephson Neil | Award | 31.00K | — |
Short interest
Settled Nov 15, 2018
- Shares short
- 7.96K
- Days to cover
- 1.00
- % of shares outstanding
- —
- Average daily volume
- 9.86K
- Change since last report
- +311.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.